Creator of wearable sustained acoustic medicine technology to educate clinicians on device's effectiveness in soft tissue healing and regenerative medicine treatment.

curasan AG, listed in the General Standard of the German Stock Exchange, was able to achieve an annual surplus of 0.2 million Euro in the fiscal year 2009